Back

Low risk obese patient with persistently elevated mean LDL-C =141 mg/dl, who is not willing to use statins. To treat or not to treat?

16 April 2021 (09:45 - 10:00)
Organised by:
Congress Presentation Part of: Clinical cases session - Primary care and risk factor management Risk Factors and Prevention EAPC Premium Access ESC Preventive Cardiology 2021

About the speaker

Photo
Associate Professor Arrigo Francesco Giuseppe Cicero

Alma Mater Studiorum, University of Bologna, Bologna (Italy)

1 More presentation in this session

Presentation thumbnail
Low risk obese patient with persistently elevated mean LDL-C =141 mg/dl, who is not willing to use statins. To treat or not to treat? - discussion

Access the full session

Session thumbnail
Clinical cases session - Primary care and risk factor management
Video

The Event

Event poster

ESC Preventive Cardiology 2021

16 April 2021 09:45 CET
You may be interested in
thumbnail
Congress Presentation
The current LDL-C target <1.4mmol/l of the ESC is achieved in less than 16% of patients with Coronary Heart Disease despite effective lipid-lowering therapy: Data from the LLT-R registry
28 August 2020
thumbnail
Webinar
How to treat patients with borderline dyslipidemia
8 February 2023
thumbnail
Congress Presentation
Pooled safety and efficacy of inclisiran in patients with statin intolerance (ORION-10 and ORION-11)
30 August 2020
thumbnail
Congress Presentation
Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy
24 June 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources